Total planned funding: $570,884,963
Allocations
Countries/Regions
Nigeria | $93,568,785 |
Tanzania | $79,000,015 |
Zambia | $66,189,554 |
Mozambique | $62,094,359 |
Ethiopia | $54,162,102 |
Côte d'Ivoire | $44,256,500 |
Uganda | $38,140,633 |
Rwanda | $28,875,535 |
Vietnam | $25,892,348 |
South Africa | $23,839,879 |
Zimbabwe | $21,403,173 |
Haiti | $11,481,695 |
Namibia | $8,177,496 |
Kenya | $4,649,885 |
Guyana | $3,209,493 |
Botswana | $2,252,690 |
Democratic Republic of the Congo | $1,400,000 |
Burundi | $1,307,821 |
Lesotho | $400,000 |
Malawi | $300,000 |
Eswatini | $249,000 |
Angola | $34,000 |
Organizational Types
Private Contractor | $570,884,963 |
Program Areas
Treatment | $570,884,963 |
Budget Codes
HTXD: Treatment: ARV Drugs | $438,338,850 |
HTXS: Treatment: Adult Treatment | $122,250,553 |
PDTX: Treatment: Pediatric Treatment | $10,295,560 |
Top Partner Programs
Deloitte Consulting Limited:
$22,840,411
View countries
Henry M. Jackson Foundation for the Advancement of Military Medicine:
$9,337,312
View countries
All Countries
2013 | $9,337,312 |